Margarida Azevedo, MSc, —
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Articles by Margarida Azevedo
Recent Posts
- Despite the side effects, Soliris has given me another chance at life
- Researchers identify novel CD46 gene mutation underlying aHUS
- I remember aHUS, 6 weeks in the ICU, and 17 new medications
- Influenza, COVID-19 are trigger events for aHUS in man, 19
- My edema management is becoming increasingly difficult
- Scientists urge heart screening for aHUS patients
- On the 5-year anniversary of my diagnosis, I’m grateful to be alive
- For Awareness Day 2025, advocates to focus on ways to manage aHUS
- My favorite tips to make life with aHUS a little easier
- Switching from Soliris to Ultomiris is safe after kidney transplant